Value of intermediates in drug design – example of novel L-ascorbic acid derivatives (CROSBI ID 651305)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Stepanić, Višnja ; Meščić, Andrijana ; Harej, Ana ; Kraljević Pavelić, Sandra ; Raić-Malić, Silvana
engleski
Value of intermediates in drug design – example of novel L-ascorbic acid derivatives
In our search of new hybrids of L-ascorbic acid and diverse pharmacophoric scaffolds as potential anticancer agents, novel conjugates of 1, 2, 3- triazole and L-ascorbic acid are synthesized using Cu(I) catalyzed click reaction (CuAAC) [1, 2]. Herein considered dibenzylated compounds are obtained as intermediates in the synthesis of target derivatives of vitamin C. The library of compounds with reasonable ADME/Tox profile is designed in a way to span physicochemical space by varying a substituent at position R1 of 1, 2, 3- triazole ring and by elimination of C5-OH group and introduction of C4=C5 double bond (Fig. 1).
ascorbic acid ; ADMET ; antiproliferative ; PCA
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
91-91.
2017.
objavljeno
Podaci o matičnoj publikaciji
6th IAPC Meeting , Sixth World Conference on Physico-Chemical Methods in Drug Discovery & Third World Conference on ADMET and DMPK : Book of Abstracts
Mandić, Zoran
Zagreb: International Association of Physical Chemists (IAPC)
Podaci o skupu
6th IAPC Meeting: Sixth World Conference on Physico-Chemical Methods in Drug Discovery & Third World Conference on ADMET and DMPK
poster
01.01.2017-01.01.2017
Zagreb, Hrvatska